Gait Analysis Parameter and Upper Limb Evaluation in Control Participants
NCT: NCT07136506 · RECRUITING
Brief Summary
The ActiControl study is a monocentric, academic, and fully remote observational study designed to build a normative, longitudinal dataset using the Syde® wearable device. The study will enroll 200 healthy volunteers across all age groups, genders, and backgrounds. Participants will be remotely recruited and followed over two years, wearing the Syde® device for 3-week periods every 6 months. All study visits, including consent, data collection, and follow-up, are conducted remotely via phone or video conferencing. The primary objectives are to collect reference data on gait and movement patterns and to assess adherence and acceptability of the device. Secondary objectives include evaluating the reliability of digital endpoints and the influence of demographic and lifestyle factors on these measures.
Frequently Asked Questions
What is Gait Analysis Parameter and Upper Limb Evaluation in Control Participants?
Gait Analysis Parameter and Upper Limb Evaluation in Control Participants is a clinical trial registered under NCT07136506. Current status: RECRUITING.
What is the status of NCT07136506?
The current status of NCT07136506 (Gait Analysis Parameter and Upper Limb Evaluation in Control Participants) is: RECRUITING.
When did Gait Analysis Parameter and Upper Limb Evaluation in Control Participants start?
Gait Analysis Parameter and Upper Limb Evaluation in Control Participants started on 2025-09-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.